Seprina3 is highly expressed in AT, where it regulates preadipocyte differentiation, AT inflammation, and tumour necrosis factor alpha (TNF-α)-induced insulin resistance [43,44,45]. The gene discussed is TNF; the disease is Insulin resistance.